Jul 7, 2026 07:00AM
Jul 7, 2026 07:00AM
Jun 26, 2026 07:00AM
Jun 26, 2026 07:00AM
Jun 18, 2026 07:00AM
Jun 18, 2026 07:00AM
Jun 15, 2026 07:02AM Axsome Therapeutics presents sleep disorder data at SLEEP 2026 conference
Jun 15, 2026 07:00AM
Jun 4, 2026 07:00AM
Jun 4, 2026 06:40AM
Jun 3, 2026 07:04AM
Jun 3, 2026 07:00AM
Jun 1, 2026 07:03AM
Jun 1, 2026 07:00AM Axsome Therapeutics Partners with the Headache Alliance to Highlight the Impact of Migraine During Migraine and Headache Awareness Month
May 27, 2026 07:00AM
May 26, 2026 07:00AM
May 7, 2026 07:00AM
May 5, 2026 07:00AM
May 4, 2026 01:15PM
May 4, 2026 07:33AM
May 4, 2026 07:00AM Axsome Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
May 1, 2026 07:15AM
May 1, 2026 07:15AM
Apr 30, 2026 05:15PM
Apr 30, 2026 02:06PM
Apr 30, 2026 02:06PM
Apr 10, 2026 09:31AM
Apr 8, 2026 07:00AM Axsome Therapeutics to Report First Quarter 2026 Financial Results on May 4
Apr 1, 2026 05:41PM
Apr 1, 2026 07:00AM
Apr 1, 2026 07:00AM
Mar 25, 2026 06:07AM
Feb 25, 2026 07:00AM
Feb 24, 2026 07:00AM
Feb 24, 2026 07:00AM Axsome Therapeutics Initiates CLARITY Phase 3 Trial of Solriamfetol in Adults with Major Depressive Disorder with Excessive Daytime Sleepiness Symptoms
Feb 23, 2026 12:17PM
Feb 23, 2026 07:00AM
Feb 18, 2026 07:00AM
Feb 17, 2026 07:00AM
Jan 27, 2026 07:00AM
Jan 15, 2026 07:00AM
Jan 15, 2026 07:00AM Axsome Therapeutics Initiates FORWARD Phase 3 Trial of AXS-14 for the Management of Fibromyalgia
Jan 12, 2026 07:08AM
Jan 12, 2026 07:00AM
Jan 8, 2026 03:37AM
Jan 5, 2026 06:40AM
Jan 2, 2026 06:23AM
Dec 31, 2025 01:54PM
Dec 31, 2025 01:20PM Leerink on Axsome Therapeutics (AXSM): 'This is very positive news'
Dec 31, 2025 01:19PM

325,416 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All